Departments of Gastroenterology, Southwest Hospital, Army Military Medical University, Chongqing, China.
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2539-2547. doi: 10.26355/eurrev_201903_17402.
The function of MDR3 is important in bile acid transport. The miRNAs can suppress the expression of gene through combining mRNA of target gene. The regulation about MDR3 mediated by FXR or PPARα in cholestasis is clear, but the mechanism through miRNA is hardly reported. We aimed to find out the miRNA, which could suppress MDR3 expression and the significance of this connection in cholestasis.
We measured hsa-miR-378a-5p expression level in liver tissues from 20 patients with cholestasis and 15 patients without cholestasis by quantitative PCR. We also tested the level of clinical features of the same group. HepG2 cell lines were performed experiments to discover the connection between hsa-miR-378a-5p and MDR3, including transient transfection, RNA and protein extraction, qPCR, Western blotting and luciferase reporter assay.
A significant decrease of miR-378a-5p was observed in obstructive cholestasis patient liver tissues compared to control group. We also find that the miR-378a-5p expression is correlated to several clinical features, which are important biomarkers in cholestatic liver injury. Then we predicted that MDR3 may be the target gene of miR-378a-5p through miRanda v3.3a. We programed the transient transfection of mimics and inhibitor on HepG2 cell lines, and detected the mRNA and protein expression of MRP2, MRP3 and MDR3. The results suggested that miR-378a-5p could negatively regulate MDR3 expression in both mRNA and protein expression level, and this regulation is specific. We didn't find same regulation in MRP2 and MRP3. Dual luciferase assays proved this regulation is mediated by a direct binding between miR-378a-5p and CDS of MDR3.
We found that hsa-miR-378a-5p expression was down-regulated in cholestatic liver tissues, compared to control liver tissues. Transient transfection and luciferase reporter assay in HepG2 cell lines results suggest that hsa-miR-378a-5p can directly combine MDR3 mRNA and suppress MDR3 protein expression. The down-regulated hsa-miR-378a-5p may cause a protective alteration through up-regulating MDR3 expression in cholestasis.
MDR3 的功能对于胆酸转运非常重要。miRNA 可以通过结合靶基因的 mRNA 来抑制基因的表达。在胆汁淤积中,FXR 或 PPARα 对 MDR3 的调节作用较为明确,但通过 miRNA 的调控机制却鲜有报道。本研究旨在寻找能够抑制 MDR3 表达的 miRNA,并探讨其在胆汁淤积中的意义。
采用实时定量 PCR 方法检测 20 例胆汁淤积患者和 15 例非胆汁淤积患者肝组织中 hsa-miR-378a-5p 的表达水平,并对同一组患者的临床特征进行检测。采用 HepG2 细胞系进行实验,以发现 hsa-miR-378a-5p 与 MDR3 之间的关系,包括瞬时转染、RNA 和蛋白质提取、qPCR、Western blot 和荧光素酶报告基因检测。
与对照组相比,梗阻性胆汁淤积患者肝组织中 miR-378a-5p 的表达明显降低。我们还发现,miR-378a-5p 的表达与几个临床特征相关,这些特征是胆汁淤积性肝损伤的重要生物标志物。然后,我们通过 miRanda v3.3a 预测 MDR3 可能是 miR-378a-5p 的靶基因。我们在 HepG2 细胞系中编程转染 mimics 和 inhibitor,并检测 MRP2、MRP3 和 MDR3 的 mRNA 和蛋白质表达。结果表明,miR-378a-5p 可在 mRNA 和蛋白质表达水平上负调控 MDR3 表达,且这种调控具有特异性。我们未发现对 MRP2 和 MRP3 的相同调控。双荧光素酶报告基因实验证实这种调控是由 miR-378a-5p 与 MDR3 CDS 的直接结合介导的。
与对照组肝组织相比,胆汁淤积患者肝组织中 hsa-miR-378a-5p 的表达下调。HepG2 细胞系中的瞬时转染和荧光素酶报告基因检测结果表明,hsa-miR-378a-5p 可直接结合 MDR3 mRNA,抑制 MDR3 蛋白表达。在胆汁淤积中,下调的 hsa-miR-378a-5p 可能通过上调 MDR3 表达引起保护性改变。